Diuretics and Vitamin B,: Are Diuretics a Risk Factor for Thiamin Malnutrition? by Suter, Paolo M. & Vetter, Wilhelm
Diuretics and Vitamin B,: Are Diuretics a Risk Factor for Thiamin 
Ma1 n u t r i t ion? 
Despite modern pharmacologic agents in the 
therapy of heart failure, the prevalence of heart 
failure is increasing worldwide. In the vitamin 6, 
deficiency disease beriberi, cardiac symptoms may 
represent the central feature. Two new studies 
confirmed that all diuretics lead to increased uri- 
nary thiamin excretion depending on the urinary 
flow rate. In a subject at risk, such as an elderly 
patient, chronic diuretic treatment may lead to a 
subclinical thiamin deficiency. Whether subclini- 
cal thiamin nutriture is a modulator of the preva- 
lence andlor severity of heart failure is not known; 
however, it seems to be plausible from the meta- 
bolic point of view. 
Diuretics represent the pharmacologic cornerstone in the 
therapy of hypertension and congestive heart fai1ure.l The 
therapeutic effect of diuretics is mainly mediatea by in- 
creased urinary salt and volume excretion.2 The side ef- 
fects of diuretics are well known, and one of the most 
important side effects of diuretics is hypokalemia owing 
to the increased urinary loss of potassium? All clinicians 
and many patients are aware of this side effect because 
hypokalemia may result in dangerous cardiac arrhythmias. 
Accordingly, the biochemical monitoring of plasma po- 
tassium levels represents a routine procedure in patients 
on diuretics. Nevertheless, it is less well known that di- 
uretics also increase the excretion of other electrolytes, 
minerals, and water-soluble vitamins.>ll 
The effect of diuretics on the excretion of water- 
soluble vitamins has been discussed repeatedly during 
the last 30 years; however, many clinicians and cardiolo- 
gists usually ignore the importance of these findings. The 
effect of diuretics on urinary thiamin excretion was re- 
cently addressed in two publications. One can hope that 
these studies will lead to a revival of interest in this impor- 
tant aspect of vitamin nutriture and a clarification of the 
controversy. 
Rieck et a1.I2 studied the effect of single intravenous 
1 mg, 3 mg, and 10 mg doses of furosemide compared with 
normal saline infusions on urinary thiamin excretion in six 
healthy volunteers. The different furosemide doses and 
the saline infusions resulted in a dose-dependent increase 
in urine flow and sodium excretion, which was accompa- 
nied by an increase in the urinary thiamin excretion rate. 
The urinary thiamin excretion rate doubled during an ini- 
tial observation period of 6 hours from a baseline thiamin 
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excretion rate of 6.4 f 5.1 nmolhour to 1 1.6 f 8.2 nmol/ 
hour 0, < 0.01). Thiamin excretion then returned to baseline 
levels during the following 18 hours. In these subjects, a 
significant correlation between the urinary thiamin excre- 
tion rate and the urine flow rate was observed ( r  = 0 . 5 4 , ~  
The second publication, from the same research group, 
tried to evaluate the mechanisms of furosemide-induced 
urinary thiamin e~creti0n.l~ In this study, Lubetsky et al.I3 
measured the urinary thiamin excretion in rats in response 
to increasing doses of furosemide, acetazolamide, 
chlorothiazide, amiloride, mannitol, and a saline infusion. 
In this rat studyk3 the thiamin excretion increased inde- 
pendently from the type of diuretic given and increased to 
a maximal value of 7.44-9.34 pmoVminute 0, = 0.003). There 
was no significant difference between the miscellaneous 
diuretics and the saline infusion. The thiamin excretion in 
this model correlated more or less linearly with the uriw 
volume, and the urinary flow rate explained 78% of the 
variability in thiamin excretion rates. 
The classic vitamin B, deficiency disease is beri- 
beri.14,1s In most Western countries the clinical entity of 
beriberi is only of historical importance, although at closer 
examination beriberi disease can be found in specific clini- 
cal settings, as reported in several articles and case re- 
~0rts . l”’~ Beriberi disease has two major clinical manifes- 
tations: dry beriberi, prominently featuring encephalopa- 
thy and peripheral neuropathy, and wet beriberi, in which 
high output cardiac failure with peripheral edema repre- 
sents the main clinical feature.2O Thiamin plays an impor- 
tant role in the function of the cardiac muscle and the 
maintenance of adequate heart functi0n.2’”~ Theoretically, 
any condition leading to a suboptimal nutritional status 
of this vitamin may lead, in the long run, to impaired car- 
diac function. 
The well-known deficiency diseases of thiamin are 
the Wernicke-Korsakoff syndrome and lactic a ~ i d o s i s . ~ ~ ~ ~ ~  
Both conditions are well known to most clinicians, which 
may be one of the reasons that the classical beriberi heart 
disease has been forgotten during the last few decades. 
There is no doubt that diuretics do increase the ex- 
cretion of thiamin; nevertheless, there is controversy about 
the pathophysiologic and clinical importance of the in- 
creased urinary losses of thiamin. All studies reported the 
acute effects of diuretics on thiamin excretion. It is not 
known, however, whether chronic diuretic ingestion leads 
to renal adaptation with reduced urinary thiamin excre- 
tion. 
By comparison with other vitamins, such as the lipid- 
soluble vitamins, thiamin body stores are rather small and 
whole-body thiamin stores are only approximately 30 mgF6 
< 0.001).12 
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In addition, vitamin B, metabolism has a high turnover 
rate with a half-life of 10-1 8 days. These characteristics of 
the vitamin imply that for the maintenance of optimal nu- 
triture a constant dietary supply of this vitamin must be 
assured. The constant dietary thiamin supply is easily 
achieved in healthy subjects eating according to the 
present Certain subgroups in the population, 
however, are at high risk for the development of vitamin B , 
deficiency; these populations include chronic alcohol 
consumers, the elderly,27s28 and probably elderly diuretic 
users. 
In the present context several questions need to be 
addressed: What is the prevalence of thiamin deficiency? 
Is the effect of medical and pathophysiologic importance? 
What is the mechanism of the diuretic-induced increase in 
thiamin excretion? Can the diuretic effects be counter- 
acted? Should diuretic consumers be supplemented with 
vitamin B,? 
As mentioned above, any condition leading to a dis- 
ruption of the continuous intake and/or loss of thiamin 
will favor the development of a deficiency state. Up to 
80% of heavy alcohol consumers have been fourd to be 
thiamin defi~ient.2~2~ Aging is associated with different 
alterations in thiamin metabolism, such as low intake and 
decreased capacity to activate the vitamin.30 Up to 50% of 
elderly persons have been found to be deficient in thia- 
min.30 Chronic diseases, institutionalization, and hospital- 
ization increase the risk for thiamin deficiency. Compared 
with other nutrients, thiamin respresents a nutrient with a 
very high potential for deficiency. 
The exact mechanism of the increased excretion of 
thiamin by diuretics is not known. The studies by Rieck et 
al.12 and Lubetsky et al.I3 suggest that the mechanism is 
nonspecific and urinary flow dependent. Lubetsky et al.l3 
compared the effect of different diuretics (furosemide, ac- 
etazolamide, chlorothiazide, amiloride) acting at different 
anatomic and functional levels of the renal tubules (loop 
of Henle, proximal tubule, distal convoluted tubule, col- 
lecting duct). In addition, they compared the effect ofthese 
diuretics with mannitol and simple extracellular volume 
expansion by the administration of saline, the latter two 
eliciting an effect on the whole nephron. Any increase in 
diuresis induced an increase in thiamin excretion indepen- 
dently from the applied strategy to increase urinary flow.13 
This suggests that the phenomenon is only related to the 
increased urinary flow and not any specific effect on thia- 
min secretion or resorption. They report that urinary flow 
rates accounted for 78% of the variability in the thiamin 
excretion rates upon the different interven+’ms. These 
rather strong data from the carefully performed studies by 
Lubetsky et aI.I3 and Rieck et a1.I2 are very supportive of 
the thiamin-loosing effect as a phenomenon of all diuret- 
ics. Nevertheless, in earlier studies potassium-sparing di- 
uretics have not been found to increase urinary thiamin 
exc re t i~n .~ .~ ’  This discrepancy can be explained by 
methodologic issues regarding the design of the study 
and the animal model used, as well as the diuretic type and 
dosage applied. The suggested urinary flow dependency 
of the diuretic-induced thiamin loss also receives indirect 
support from evidence of thiamin deficiency in hemodi- 
alysis patients.32 
Thiamin excretion in humans depends mainly on the 
blood thiamin concentration. Under normal conditions, 
i.e., in the absence of kidney disease and/or diuretic in- 
take, at low blood levels hardly any thiamin is excreted 
because tubular reabsorption of this vitamin is enhanced 
in this clinical condition.33 With increasing intakes and 
blood levels, thiamin excretion rises sharply. According to 
the present evidence, diuretics seem to disrupt these regu- 
latory mechanisms, thus increasing the risk for deficiency. 
The increased diuretic associated risk for vitamin B, defi- 
ciency underlines the importance of monitoring thiamin 
status when prescribing diuretics to subjects at risk, i.e., 
elderly persons. 
The regulation of urinary excretion of thiamin is not 
well understood. Nevertheless, it is evident that the di- 
uretic-induced increase in thiamin excretion in subjeets 
with high plasma thiamin levels is probably of no clinical 
or pathophysiologic importance as long as high plasma 
levels can be maintained. In elderly subjects, higher plasma 
thiamin levels are not always easily achieved, thus predis- 
posing them t,o a higher risk for thiamin deficiency when 
taking diuretics. 
Several smaller studies reported impaired thiamin nu- 
triture in patients with congestive heart failure and con- 
comitant diuretic thera~y.4,~~ Some studies could not show 
a thiamin deficiency in patients with similar diag- 
n o s e ~ . ~ ~ , ~ ~ * ~ ~  These inconsistent results are not surprising 
and probably can be explained by the metabolic charac- 
teristics of thiamin as well as by the potential differences 
in thiamin intake as a function of different eating habits 
(e.g., high-carbohydrate versus low-carbohydrate diets) 
and food preparation habits (e.g., long cooking and stor- 
ing), and also by the different levels of physical activity of 
studied  population^.^ In addition, most of the normal 
plasma values for vitamins-including vitamin B ,-are 
based on the concept of prevention of the classic defi- 
ciency diseases and not necessarily on functional param- 
eters (such as heart function). 
It is conceivable that plasma levels in the upper range 
of normal, or even supranormal, in patients with heart fail- 
ure may lead to favorable pharmacologic effects at the 
level of the heart. Miscellaneous pharmacologic effects 
for vitamins have been reported and it is not far-fetched to 
suggest that normal plasma thiamin levels in heart failure 
patients may not be adequate for optimal organ function 
of the diseased heart. This concept is also supported by a 
small intervention trial reporting an improvement of left 
ventricular function in patients with congestive heart fail- 
ure on diuretic therapy following short-term supplemen- 
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tation with thiamin.34 In patients with normal biochemical 
vitamin B, status, the parenteral short-term supplementa- 
tion of 200 mg/day for l week followed by a 6-week oral 
supplementation regimen with the same dosage led to sig- 
nificant improvement (by 22%) of the left ventricular ejec- 
tion fraction. The improvement of left ventricular function 
in this study34 was apparent after the first week of therapy. 
Although the response pattern in this study was very 
heterogeneous, the effect of the supplementation reached 
the level of significance. 
The importance of functional testing in the assess- 
ment of a suboptimal nutritional status is very important. 
This is also reflected in the results of a recent study re- 
porting increased homocysteine levels in hypertensive 
patients on long-term diuretic therapy.37 The increased 
homocysteine levels represent a marker for a functional 
impairment of vitamin-dependent metabolic clearing path- 
ways of homocysteine. In the study by Morrow et al.37 
diuretic use was associated with decreased plasma folate 
levels, although the plasma folate levels remained within 
normal limits. In view of the normal folate plasmadevels, 
no folate supplementation would be warranted. Neverthe- 
less, the increased homocysteine levels represent a marker 
for a deficiency and a rather clear indication for supple- 
mentation. In a recent prospective study evaluating the 
change in nutritional status of patients during hospital- 
ization in a medical clinic, a relationship between the cu- 
mulative diuretic dosage given during the hospitalization 
and the decline in vitamin B, nutriture was reported.38 
Certain patients and population groups can cot ob- 
tain all essential nutrients from the diet alone, which is 
often also the case for vitamin B,. The major food sources 
ofvitamin B, are wheat germ, whole grain products, yeast, 
nuts, and meat products. Approximately 40% of dietary 
thiamin is ingested in the form of cereals and cereal prod- 
ucts; it must be remembered, however, that the usual food 
processing techniques may considerably reduce the food 
content of this  ita am in.'^ Most chronic diuretic users are 
elderly persons, and it is not easy to recommend to this 
population group the ingestion of whole grain products, 
owing to potential digestion problems. In addition, thia- 
min is very heat labile, and depending on the cooking 
techniques up to 80% of the vitamin can be destroyed.39 
Food services for elderly persons depend on rather long 
food preparation procedures (including cooking, storage, 
and transport while keeping the food hot), which lead to a 
considerable loss of this very heat-sensitive vitamin. A 
diet high in carbohydrates (mainly in the form of simple 
sugars) is associated with an increased risk of thiamin 
deficiency.6.16 Accordingly, it seems prudent to support 
the concept of pharmacologic improvement of vitamin B, 
nutriture in elderly patients on chronic diuretic therapy. A 
safe and ideal vitamin B, dosage for elderly patients on 
chronic diuretic therapy should be higher than the present 
dietary recommendations; a dosage of 20-50 mglday 
seems reasonable. 
Alcohol abuse represents the single most important 
risk factor for thiamin deficiency in Western countries. 
Owing to the high impact of alcohol on thiamin nutriture, 
fortification of alcoholic beverages has been suggested.4O 
It can therefore be hypothesized that a combined formula- 
tion of a diuretic with thiamin may bear some therapeutic 
advantage in certain clinical settings such as heart failure 
in elderly persons. 
Despite the high potential for cardiac function im- 
provement upon thiamin supplementation in elderly pa- 
tients with cardiac failure, there may be insufficient clini- 
cal improvement of cardiac function in selected patients. 
There may be several causes for this unresponsiveness, 
such as disease progression, noncompliance with phar- 
macologic therapy, and magnesium deficiency. Chronic 
diuretic use may lead to an increased urinary loss of mag- 
nesium and subclinical magnesium d e f i c i e n ~ y . 4 ~ ~ ~  Mag- 
nesium plays a central role in heart muscle 
and in the activation of thiamin to thiamin pyrophosphate, 
the active form of the vitamin.& The prevalence of magne- 
sium deficiency in chronic diuretic users may be rather 
high, predisposing them to an insufficient metabolic acti- 
vation of vitamin B,. Accordingly, to obtain an optimal 
clinical response to vitamin B, supplements, adequate 
magnesium status has to be maintained. The role of mag- 
nesium in thiamin metabolism is also nicely supported in a 
case report describing the occurrence of Wernicke's en- 
cephalopathy induced by magnesium def i~ iency .~~ In the 
present context, it must be remembered that potassium- 
sparing diuretics do have magnesium-conserving proper- 
Aging is also regarded as a risk factor for magne- 
sium thus enhancing the risk for an impair- 
ment of thiamin status. 
Besides interacting at the level of the kidney, some 
cardiac drugs may interfere with thiamin metabolism at the 
level of the cardiac cells. It has been reported that furo- 
semide and digoxin inhibit thiamin uptake by cardiac cells 
in which would represent another potentially 
unfavorable effect of diuretics on thiamin nutriture and 
heart function. The clinical importance of the effect of 
diuretics on thiamin uptake by cardiac cells is not known. 
Pharmacoepidemiologic data underline the potential 
importance of diuretics in the present context. More than 
50% of elderly subjects (> 65 years) received diuretics in a 
recent survey from the Netherlands.' The prescription rates 
of loop diuretics increased from 15% in patients ages 65- 
74 years to more than 30% in patients ages 85 years or 
older., Most elderly persons also receive additional drugs, 
which may interfere with other nutrients and food intake 
and, therefore, thiamin intake. 
Owing to the increasing prevalence of heart failureSo 
and the lack of danger of thiamin toxicity, a supplementa- 
tion trial with thiamin combined with the usual medical 
therapy in elderly heart failure patients seems to be war- 
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ranted. The cost of heart failure is so high” that the addi- 
tion of a safe and cheap therapeutic option should not be 
discounted. Such a therapeutic trial could be very advan- 
tageous because any favorable effects may be seen within 
a few days, at minimal cost, and with no side effects. 
The prevalence of frank vitamin B, deficiency in car- 
diac failure patients is not known. AFrench study52 found 
no significant difference in the thiamin status of 35 elderly 
hospital inpatients with cardiac failure compared with 
matched patients with other diagnoses. Nevertheless, 
1 1.5% of the cardiac failure patients were found to be de- 
ficient compared with 6% in the control group; in addi- 
tion, thiamin deficiency was more frequent in the func- 
tional class of New York Heart Association (NYHA) IV 
compared with NYHA HI. 
In clinical practice there is no need to assess the bio- 
chemical vitamin B, nutriture in every patient with heart 
failure because the biochemical assessment of vitamin B, 
nutriture is difficult and an adequate handling of the blood 
during the preanalytic stage is rarely assured in a routine 
hospital setting. The clinical setting (an elderly multimorbid 
patient on chronic diuretic therapy and inadequatC food 
intake) should be the trigger for the consideration of a 
thiamin supplementation trial. One central risk indicator 
for vitamin B, deficiency is poor appetite. The differential 
diagnosis of a poor appetite is broad; nevertheless, Kwok 
et al.l0 identified poor appetite as an indicator of impaired 
thiamin nutriture in elderly patients with congestive heart 
failure. 
These two new studies1*J3 will hopefully lead to a 
revival of interest in this neglected area of medicine. The 
prevalence of cardiac failure is increasing worldwide and 
represents a leading cause of morbidity and mortality and 
impaired quality of life in elderly persons. From the view- 
point of metabolic cardiology, the evidence of the impor- 
tance of thiamin in cardiac metabolism and function seems 
convincing. Randomized prospective placebo-controlled 
studies are still needed. In view of the fast response rate 
upon supplementation-within a few days-and the in- 
creasing “availability” of heart failure patients as sub- 
jects, final clarifying evidence can be obtained quickly. 
Until there is more convincing evidence, a high level 
of clinical suspicion and the generous supplementation 
of thiamin in high-risk patients is probably the best strat- 
egy to combat deficiency and lead to an improved quality 
of life in many patients. 
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